SMARCB1/INI1 and p53 expression impacts aggressive features of tumors. (A) Frequency of the four CRC categories according to the various combinations of p53 and SMARCB1/INI1 expression. (B) OS analysis for each category referred to all tumor stages (I-IV) (C) The same analysis is carried out taking into account only tumor stages I-II. (D) Frequency of liver metastasis according to the various combinations of p53/ SMARCB1/INI1 expression. M0 and M1 indicate absence or presence of liver metastases, respectively. The p value is reported in each graph.